Motohide Sato

Comparative Study of Glucocorticoids, Cyclosporine A, and JTE-607 [(-)-Ethyl-N-{3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl}-l-phenylalaninate Dihydrochloride] in a Mouse Septic Shock Model

K. Wakitani, H. Iwamura, Motohide Sato, 2004, Journal of Pharmacology and Experimental Therapeutics.

Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors.

S. Ikeda, H. Kawakami, Yoshiharu Ito, 2009, Journal of medicinal chemistry.

Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.

Satoru Ikeda, Yuji Matsuzaki, Yoshiharu Ito, 2006, Journal of medicinal chemistry.

Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)

M. Matsuoka, S. Ikeda, E. Kodama, 2007, Journal of Virology.

Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1-Nrf2 PPI Inhibitor.

Naoki Ogawa, A. Nomura, T. Adachi, 2023, ACS medicinal chemistry letters.

Elvitegravir: Novel Quinolone HIV‐1 Integrase Strand Transfer Inhibitor

Y. Matsuzaki, H. Shinkai, Motohide Sato, 2011 .

Lead generation and optimization of novel GPR119 agonists with a spirocyclic cyclohexane structure.

Junji Mizukami, S. Fukuda, Takashi Watanabe, 2019, Bioorganic & medicinal chemistry letters.

Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists.

Junji Mizukami, S. Fukuda, Takashi Watanabe, 2019, Bioorganic & Medicinal Chemistry Letters.